Qube Research & Technologies Ltd
Position in ALHC — Alignment Healthcare, Inc.
CIK 1729829
LONDON, X0
Position in ALHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$26,747,019
-$3,151,558 QoQ
Shares Held
1,517,992
+0.3% QoQ
Ownership
0.732%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALHC Over Time
Shares Held
Position Value (USD)
Position in Healthcare Plans
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $1,210,283,517 across 7 Healthcare Plans names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UNH |
Unitedhealth Group Inc
|
1,405,937 | $584,349,595 | |
| 2 | ELV |
Elevance Health, Inc.
|
640,181 | $247,577,198 | |
| 3 | CNC |
Centene Corp
|
2,047,184 | $131,408,740 | |
| 4 | CVS |
CVS HEALTH Corp
|
1,147,850 | $118,745,082 | |
| 5 | CI |
Cigna Group
|
347,852 | $95,895,839 | |
| 6 | OSCR |
Oscar Health, Inc.
|
1,083,939 | $30,913,940 | |
| 7 | PGNY |
Progyny, Inc.
|
48,322 | $1,393,123 |
All Filings in ALHC
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,747,019 | 1,517,992 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,898,577 | 1,513,852 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,767,600 | 960,894 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,335,804 | 1,523,986 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,677,044 | 412,301 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $770,546 | 68,493 | Shares | Sole | 2025-02-14 | |
| 2023-06-30 | $124,872 | 21,717 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $144,130 | 22,662 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,404,755 | 119,452 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $929,582 | 78,512 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||